Last reviewed · How we verify
Placebo of ADC189 tablets — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of ADC189 tablets (Placebo of ADC189 tablets) — Jiaxing AnDiCon Biotech Co.,Ltd. This is a placebo control formulation used in clinical trials and contains no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of ADC189 tablets TARGET | Placebo of ADC189 tablets | Jiaxing AnDiCon Biotech Co.,Ltd | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of ADC189 tablets CI watch — RSS
- Placebo of ADC189 tablets CI watch — Atom
- Placebo of ADC189 tablets CI watch — JSON
- Placebo of ADC189 tablets alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of ADC189 tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-adc189-tablets. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab